[1] De Kouchkovsky I. Acute myeloid leukemia: a comprehensive review and 2016 update'[J].Blood Cancer J,2016,6(7):e441.
[2] Chamberlain MC. Neoplastic meningitis[J].Neurologist,2006,12:179-187.
[3] Chamberlain MC, Glantz M, Groves MD,et al.Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment[J].Semin Oncol,2009,36(4 Suppl 2):S35-S45.
[4] Martínez-Cuadrón D.Central nervous system involvement at first relapse in patients with acute myeloid leukemia[J].Haematologica,2011,96(9):1375-1379.
[5] Sancho JM.Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosis[J].Int J Hematol,2007,86(1):33-36.
[6] Jabbour E, O'Brien S, Kantarjian H,et al.Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia[J].Blood,2007,109(8):3214-3218. |
2019, Vol. 36 
